Stockscreener 앱 받기
1.57
4.85%
-0.08
시간 외 거래:
1.57
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in
Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Bluffton Today
Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com
Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus
Protagenic reports positive safety results for stress disorder drug - Investing.com
Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Australia
Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire
What Makes Kalyan Jewellers India Limited Stand Out Among CompetitorsSupport and Resistance Levels & Minimal Investment Portfolio - earlytimes.in
Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser
Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser
Can Protagenic Therapeutics Inc. (MBP0) stock expand revenue streamsJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser
How dovish Fed policy supports Protagenic Therapeutics Inc. (MBP0) stockQuarterly Market Review & Free High Return Stock Watch Alerts - Newser
Is Protagenic Therapeutics Inc. Equity Warrant stock positioned well for digital economy2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - Newser
Is Protagenic Therapeutics Inc. stock gaining market shareJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Can Protagenic Therapeutics Inc. (MBP0) stock attract ESG investmentsJuly 2025 Rallies & Technical Pattern Alert System - Newser
CapEx per share of Protagenic Therapeutics, Inc. – GETTEX:MBP0 - TradingView
Will Protagenic Therapeutics Inc. Equity Warrant stock attract ESG investorsMarket Sentiment Review & Daily Momentum Trading Reports - Newser
How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cycles2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Why Protagenic Therapeutics Inc. (MBP0) stock could be next leaderJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Protagenic Therapeutics (PTIX) Stock Analysis Report | Financials & Insights - Benzinga
How robust is Protagenic Therapeutics Inc. (MBP0) stock financial position - Newser
Why Protagenic Therapeutics Inc. (MBP0) stock is a must watch tickerMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
ETF Watch: Can Protagenic Therapeutics Inc stock maintain growth trajectoryGlobal Markets & Entry Point Strategy Guides - BỘ NỘI VỤ
US Stocks Recap: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryGDP Growth & Proven Capital Preservation Tips - BỘ NỘI VỤ
Protagenic Therapeutics Faces Nasdaq Delisting Due to Compliance Issues - marketscreener.com
Can Protagenic Therapeutics Inc. stock maintain growth trajectoryEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
Protagenic Therapeutics, Inc. (PTIX) Stock: Faces Nasdaq Delisting Risk Amid Equity and Filing Issues - parameter.io
Can Protagenic Therapeutics Inc. stock attract ESG capital inflowsDollar Strength & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Protagenic Therapeutics receives Nasdaq non-compliance letter - MSN
Does Protagenic Therapeutics Inc (PTIX) offer a good opportunity for investors? - Setenews
Protagenic Therapeutics (PTIX) Faces Nasdaq Delisting Over Compl - GuruFocus
Protagenic Therapeutics (Nasdaq: PTIX) hit with Nasdaq notice for $2.5M deficit, late 10-Q - Stock Titan
Protagenic Therapeutics Faces Nasdaq Delisting Notice - MSN
Protagenic Therapeutics, Inc. (PTIX) -8.1% in After-hours: Stock Declines Despite Recent Milestones - Stocks Telegraph
Protagenic Therapeutics, Inc.\new SEC 10-Q Report - TradingView
Protagenic Therapeutics gets Nasdaq notice for equity and filing issues - Stock Titan
Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsJuly 2025 PostEarnings & Growth Oriented Trade Recommendations - BỘ NỘI VỤ
Protagenic Therapeutics Inc MBP0 Stock Analysis and ForecastEarnings Date Calendar & Affordable Stock Market Tips - earlytimes.in
Atrinsic (NASDAQ:PTIX) Trading Up 2.5% – Time to Buy? - Defense World
Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish - MSN
Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Protagenic Therapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsTrade Entry Summary & Proven Capital Preservation Methods - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock a buy before product launches2025 Macro Impact & Verified Momentum Watchlists - newser.com
What analysts say about Protagenic Therapeutics Inc Equity Warrant stockCapital Gains Strategies & Minimal Capital Growth Plans - earlytimes.in
How Protagenic Therapeutics Inc. Equity Warrant stock reacts to bond yieldsMarket Sentiment Review & Daily Momentum Trading Reports - newser.com
0.36%
1.05%
자본화:
|
볼륨(24시간):